
By Mariam Sunny
(Reuters) -Global measles cases fell 71% to 11 million from the year 2000 to 2024, driven by improved vaccination coverage, the World Health Organization said in a report on Friday.
Vaccination has prevented nearly 59 million deaths globally during this period, according to the report.
Deaths dropped even more sharply by 88% to 95,000 in 2024, among the lowest annual tolls since 2000.
However, estimated cases in 2024 rose 8%, while deaths dropped 11%, compared with 2019 pre-pandemic levels, reflecting a shift in disease burden from low-income to middle-income countries, which have lower fatality ratios, the report said.
Measles is often the first disease to see a resurgence when vaccination coverage drops, the agency said, adding that growing measles outbreaks expose weaknesses in immunization programmes and health systems.
Due to its high transmissibility, "even small drops in vaccine coverage can trigger outbreaks, like a fire alarm going off when smoke is detected," said Kate O'Brien, director of the Department of Immunization at WHO.
(Reporting by Mariam Sunny in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
NASA Perseverance rover sees megaripples on Mars | Space photo of the day for Jan. 7, 2026. - 2
The most effective method to Make a Dazzling Site in 5 Basic Advances - 3
A Colombian city swaps iconic horse buggies for electric carriages amid animal welfare concerns - 4
A Past filled with Old Civilizations: The World's Most established Societies - 5
The Ascent of Rousing Pioneers Who Formed History
Unsold Rams May Be Less expensive Than You Suspect
Unwind: Four Extraordinary Spa Resorts On the planet
Really focusing on Succulents: Tips and Procedures
A few Exemplary Chinese Dishes, Which Are Famous Around the world
How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
Vote In favor of Your Favored Keeping an eye on
Nature carves colossal snowman in Siberia | Space photo of the day for Jan. 2, 2026
Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
Impact of NIH funding reductions felt in cancer and infectious disease trials













